用于治疗压力性尿失禁的 Macroplastique® 显示出 PET-avid 尿道病变：病例报告

IF 0.7 Q4 OBSTETRICS & GYNECOLOGY

Case Reports in Women's Health Pub Date : 2024-09-05 DOI:10.1016/j.crwh.2024.e00649

{"title":"用于治疗压力性尿失禁的 Macroplastique® 显示出 PET-avid 尿道病变：病例报告","authors":"","doi":"10.1016/j.crwh.2024.e00649","DOIUrl":null,"url":null,"abstract":"<div><p>Macroplastique® is a periurethral bulking agent used for the treatment of female stress urinary incontinence. It is composed of polydimethylsiloxane macroparticles suspended in a polyvinylpyrolidone carrier to allow injection. The patient in this case report had increased 18F-FDG avidity on PET scan at the site of prior Macroplastique® injection. This avidity was likely due to a local inflammatory response and did not represent an occult malignancy. Keen clinical judgement is necessary when this PET-avid area is demonstrated in women with prior bulking therapy as this is an incidental benign finding that does not require further invasive management.</p></div>","PeriodicalId":9657,"journal":{"name":"Case Reports in Women's Health","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214911224000705/pdfft?md5=dae6611b2f06d0d86cf9673075ebeaf9&pid=1-s2.0-S2214911224000705-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Macroplastique® for stress urinary incontinence lights up as a PET-avid urethral lesion: A case report\",\"authors\":\"\",\"doi\":\"10.1016/j.crwh.2024.e00649\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Macroplastique® is a periurethral bulking agent used for the treatment of female stress urinary incontinence. It is composed of polydimethylsiloxane macroparticles suspended in a polyvinylpyrolidone carrier to allow injection. The patient in this case report had increased 18F-FDG avidity on PET scan at the site of prior Macroplastique® injection. This avidity was likely due to a local inflammatory response and did not represent an occult malignancy. Keen clinical judgement is necessary when this PET-avid area is demonstrated in women with prior bulking therapy as this is an incidental benign finding that does not require further invasive management.</p></div>\",\"PeriodicalId\":9657,\"journal\":{\"name\":\"Case Reports in Women's Health\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2214911224000705/pdfft?md5=dae6611b2f06d0d86cf9673075ebeaf9&pid=1-s2.0-S2214911224000705-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Women's Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2214911224000705\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Women's Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214911224000705","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

Macroplastique® 是一种尿道周围膨大剂，用于治疗女性压力性尿失禁。它由悬浮在聚乙烯吡咯烷酮载体中的聚二甲基硅氧烷大颗粒组成，便于注射。本病例报告中的患者曾在注射 Macroplastique® 的部位进行 PET 扫描，结果发现 18F-FDG 反应性增高。这种嗜性可能是由于局部炎症反应引起的，并不代表隐性恶性肿瘤。当曾接受过膨体治疗的妇女出现这种正电子发射计算机断层扫描(PET)阳性区域时，有必要进行审慎的临床判断，因为这是一种偶然的良性发现，不需要进一步的侵入性治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Macroplastique® for stress urinary incontinence lights up as a PET-avid urethral lesion: A case report

Macroplastique® is a periurethral bulking agent used for the treatment of female stress urinary incontinence. It is composed of polydimethylsiloxane macroparticles suspended in a polyvinylpyrolidone carrier to allow injection. The patient in this case report had increased 18F-FDG avidity on PET scan at the site of prior Macroplastique® injection. This avidity was likely due to a local inflammatory response and did not represent an occult malignancy. Keen clinical judgement is necessary when this PET-avid area is demonstrated in women with prior bulking therapy as this is an incidental benign finding that does not require further invasive management.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Case Reports in Women's Health Medicine-Obstetrics and Gynecology

CiteScore

2.10

自引率

0.00%

发文量

审稿时长

7 days